Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Details for Australian Patent Application No. 2002223680 (hide)
International Classifications
Event Publications
7 April 2005 Application Accepted
Published as AU-B-2002223680
4 August 2005 Standard Patent Sealed
19 August 2010 Extension of Term of Standard Patents
Novartis AG The earliest first regulatory approval date provided by the patentee 07 Apr 2010 For the goods RASILEZ aliskiren/hydrochlorothiazide
2 September 2010 Extension of Term of Standard Patents
Novartis AG The earliest first regulatory approval date provided by the patentee 07 Apr 2010 For the goods RASILEZ aliskiren/hydrochlorothiazide Address for service in Australia: Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
27 January 2011 Extension granted
Novartis AG The earliest first regulatory approval date provided by the patentee 07 Apr 2010 For the goods RASILEZ aliskiren/hydrochlorothiazide Extension of Term of patent pursuant to Section 77 expires on 07 Apr 2025
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser